1. Benacerraf B (1985) Significance and biological function of class II MHC molecules. Am J Pathol 120:334–343
2. Bolhuis RLH, Van De Griend RJ, Stoter G, Mukherji B (1987) Lymphoid effector cells against tumor cells. Res Monogr Immunol 11:61–88
3. Brosman SA (1982) Experience with Bacillus Calmette-Guérin in patients with superficial bladder carcinoma. J Urol 128:27–30
4. Brosman SA (1985) The use of Bacillus Calmette-Guérin in the therapy for the bladder carcinoma in situ. J Urol 134:36–39
5. Brosman SA, Lamm DL, Van Der Meijden APM, Debruijne FMJ (1989) A practical guide to the use of intravesical BCG for the management of stage Ta, T1, CIS transitional cell cancer. EORTC Genitourinary Group Monograph 6. BCG in superficial bladder cancer. Prog Clin Biol Res 310:311–323